Estimating Long-Term Survival of Adults with Philadelphia Chromosome-Negative Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia Treated with Blinatumomab Using Historical Data

被引：0
作者：
Arie Barlev
Vincent W. Lin
Aaron Katz
Kuolung Hu
Ze Cong
Beth Barber
机构：
[1] Global Health Economics,
[2] Amgen Inc.,undefined
[3] Center for Observational Research,undefined
[4] Amgen Inc.,undefined
[5] Global Biostatistical Science,undefined
[6] Amgen Inc.,undefined
来源：
Advances in Therapy | 2017年 / 34卷
关键词：
Acute lymphoblastic leukemia; Blinatumomab; Hematology; Long-term survival; Oncology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：148 / 155
页数：7
相关论文
共 44 条
  • [1] Estimating Long-Term Survival of Adults with Philadelphia Chromosome-Negative Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia Treated with Blinatumomab Using Historical Data
    Barlev, Arie
    Lin, Vincent W.
    Katz, Aaron
    Hu, Kuolung
    Cong, Ze
    Barber, Beth
    ADVANCES IN THERAPY, 2017, 34 (01) : 148 - 155
  • [2] Long-term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab
    Topp, Max S.
    Goekbuget, Nicola
    Zugmaier, Gerhard
    Stein, Anthony S.
    Dombret, Herve
    Chen, Yuqi
    Ribera, Josep-Maria
    Bargou, Ralf C.
    Horst, Heinz-August
    Kantarjian, Hagop M.
    CANCER, 2021, 127 (04) : 554 - 559
  • [3] Frontline Blinatumomab in Older Adults with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia
    Niyongere, Sandrine
    Sanchez-Petitto, Gabriela
    Masur, Jack
    Baer, Maria R.
    Duong, Vu H.
    Emadi, Ashkan
    PHARMACEUTICALS, 2020, 13 (06) : 1 - 6
  • [4] Cost-effectiveness of blinatumomab versus salvage chemotherapy in relapsed or refractory Philadelphia-chromosome-negative B-precursor acute lymphoblastic leukemia from a US payer perspective
    Delea, Thomas E.
    Amdahl, Jordan
    Boyko, Diana
    Hagiwara, May
    Zimmerman, Zachary F.
    Franklin, Janet L.
    Cong, Ze
    Hechmati, Guy
    Stein, Anthony
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (09) : 911 - 922
  • [5] Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia
    Rambaldi, Alessandro
    Ribera, Josep-Maria
    Kantarjian, Hagop M.
    Dombret, Herve
    Ottmann, Oliver G.
    Stein, Anthony S.
    Tuglus, Catherine A.
    Zhao, Xiaoyue
    Kim, Christopher
    Martinelli, Giovanni
    CANCER, 2020, 126 (02) : 304 - 310
  • [6] Blinatumomab plus ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adults
    Couturier, Marie-Anne
    Thomas, Xavier
    Raffoux, Emmanuel
    Huguet, Francoise
    Berthon, Celine
    Simand, Celestine
    Gallego-Hernanz, Maria-Pilar
    Hicheri, Yosr
    Berger, Mathilde Hunault
    Saillard, Colombe
    Leguay, Thibaut
    Loiseau, Clemence
    Bene, Marie-Christine
    Chevallier, Patrice
    LEUKEMIA & LYMPHOMA, 2021, 62 (03) : 620 - 629
  • [7] Long-term follow-up of salvage therapy using a combination of inotuzumab ozogamicin and mini-hyper-CVD with or without blinatumomab in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia
    Jabbour, Elias
    Sasaki, Koji
    Short, Nicholas J.
    Ravandi, Farhad
    Huang, Xuelin
    Khoury, Joseph D.
    Kanagal-Shamanna, Rashmi
    Jorgensen, Jeffrey
    Khouri, Issa F.
    Kebriaei, Partow
    Jain, Nitin
    Alvarado, Yesid
    Kadia, Tapan M.
    Paul, Shilpa
    Garcia-Manero, Guillermo
    Dabaja, Bouthaina S.
    Burger, Jan A.
    DiNardo, Courtney D.
    Daver, Naval A.
    Montalban-Bravo, Guillermo
    Yilmaz, Musa
    Ohanian, Maro
    Ferrajoli, Alessandra
    Jacob, Jovitta
    Rostykus, Meagan
    Garris, Rebecca
    O'Brien, Susan
    Kantarjian, Hagop M.
    CANCER, 2021, 127 (12) : 2025 - 2038
  • [8] Blinatumomab treatment of older adults with relapsed/refractory B-precursor acute lymphoblastic leukemia: Results from 2 phase 2 studies
    Kantarjian, Hagop M.
    Stein, Anthony S.
    Bargou, Ralf C.
    Grande Garcia, Carlos
    Larson, Richard A.
    Stelljes, Matthias
    Goekbuget, Nicola
    Zugmaier, Gerhard
    Benjamin, Jonathan E.
    Zhang, Alicia
    Jia, Catherine
    Topp, Max S.
    CANCER, 2016, 122 (14) : 2178 - 2185
  • [9] International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia
    Goekbuget, Nicola
    Dombret, Herve
    Ribera, Jose-Maria
    Fielding, Adele K.
    Advani, Anjali
    Bassan, Renato
    Chia, Victoria
    Doubek, Michael
    Giebel, Sebastian
    Hoelzer, Dieter
    Ifrah, Norbert
    Katz, Aaron
    Kelsh, Michael
    Martinelli, Giovanni
    Morgades, Mireia
    O'Brien, Susan
    Rowe, Jacob M.
    Stieglmaier, Julia
    Wadleigh, Martha
    Kantarjian, Hagop
    HAEMATOLOGICA, 2016, 101 (12) : 1524 - 1533
  • [10] Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia in Adolescents and Young Adults
    Wang, Amy Y.
    Muffly, Lori S.
    Stock, Wendy
    JCO ONCOLOGY PRACTICE, 2020, 16 (05) : 231 - +
12345